Diet and fasting combo shows promise for Alzheimer's patients
NCT ID NCT06898424
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a plant-based ketogenic diet combined with intermittent fasting (called Ketoflex 12/3) could slow the progression of early-to-mid stage Alzheimer's disease. Sixty participants followed the diet, and researchers measured changes in memory and thinking using a standard test. The goal was to see if this dietary approach could help control the disease and improve cognitive function.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER TYPE DEMENTIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Istanbul Medipol Universitesi
Istanbul, 34214, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new PET tracer light up Alzheimer's plaques in the living brain?
- Could atomoxetine or metformin be the next Alzheimer's treatment?
- New study aims to catch hidden financial struggles in dementia families
- 600 seniors join quest to unlock Alzheimer's earliest secrets
- Neck bypass surgery aimed at flushing out Alzheimer's toxins begins human testing
- New hope for Alzheimer's? phase 3 trial of DMB-I begins